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INTRODUCTION
Patients with neuromuscular disease (NMD) inevitably devel-
op cough impairment due to dysfunction of the respiratory 
muscles.1 This is problematic, as impaired cough limits the 
ability of the patient to remove airway secretions.1 Cough aug-
mentation can be achieved via several manual and mechani-
cal methods.2 One such method involves the use of a mechani-
cal in-exsufflator (MI-E), which gradually inflates the lungs 
(insufflation), followed by an immediate and abrupt change 
to negative pressure. This produces a rapid exhalation (exsuf-
flation), which simulates a cough and thus moves secretions 
cephalad.3 Manually assisted coughing following maximum 
insufflation by air stacking is also an effective method for im-
proving peak cough flow (PCF) in NMD patients, as reported 
by numerous studies.4-7
However, additional methods that improve PCF further are 
needed. One possibility is combining MI-E with manual th-
rust. To our knowledge, the additional benefit of MI-E in combi-
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nation with manual thrust on the improvement of PCF has 
not been demonstrated in clinical practice, although several 
studies compared PCF created during unassisted coughing, 
during techniques involving a maximal insufflation capacity 
(MIC) maneuver combined with manually assisted coughing, 
by MI-E, and by MI-E combined with manual thrust.7
The aim of the present randomized controlled trial was to 
investigate the ability of manual thrust assistance following an 
MIC maneuver, MI-E alone, and MI-E in combination with ma-
nual thrust to improve PCF in patients with NMD and respira-
tory muscle dysfunction. To measure PCF objectively, a new 
device, the Cough Aid, was used. We previously developed and 
tested this device and confirmed that it accurately measures 
assisted PCF in patients with amyotrophic lateral sclerosis 
(ALS).8
MATERIALS AND METHODS
Study design and patient selection
In total, 40 patients (37 males, three females; average age, 
20.9±7.2 years) with NMD participated in this study. The study 
subjects were all patients with stable NMD who were on non-
invasive mechanical ventilation and familiar with MI-E at the 
time of enrollment. Patients were excluded if, during the study, 
they had pneumonia or another respiratory intercurrent in-
fection, cognitive impairment, severe bulbar dysfunction,7 or 
a tracheostomy status. All participants provided a written in-
formed consent form, and our local Ethics Committee approved 
the study protocol.
Measurement of spirometry and respiratory muscle 
strength
Forced vital capacity, maximal inspiratory pressure, and maximal 
expiratory pressure were measured as previously described.9 
Measurement of PCF using the Cough Aid device
The primary outcome measure was unassisted and assisted 
PCF, which was measured using the Cough Aid as described 
previously.8 The Cough Aid consists of two parts, namely, the 
connection part and the control part (Fig. 1A). The connection 
part is a T-shaped plastic tube that has three main air pathways: 
a patient connection port, an insufflation port, and an exsuf-
flation port. The patient connection port is connected to the 
patient’s airway via an oronasal mask. The cylindrical insuffla-
tion port is connected to the MI-E or Ambu bag via a one-way 
valve, which does not leak (Fig. 1B). The exsufflation port is 
connected to the control part. If the pushing bar of the control 
part (Fig. 1A) is not pressed, it blocks the exhaust holes such 
that the air cannot pass through the control part. However, 
when the pushing bar is pressed by cough, the airflow can pass 
through the Cough Aid to the outside of the device via the open-
ed exhaust holes, which are the only route by which air can 
exit from the device. In this situation, the spirometer can dis-
tinguish the airflow caused by the MI-E or Ambu bag from the 
airflow produced by the patient’s cough, thus allowing mea-
surement of PCF alone. During insufflation, the airstream from 
the MI-E or Ambu bag goes through the patient connection 
part entirely, and additional air can be instilled into the patient’s 
lungs up to the MIC, as the pushing bar is not pressed. The 
MIC is the volume of air that can be held in the lung with the 
glottis closed.10
PCF was measured under four different conditions: no as-
sistance, manual thrust following a MIC maneuver, MI-E, and 
MI-E in combination with manual thrust. Two investigators 
carried out the trial. One doctor used an Ambu bag or MI-E 
with the Cough Aid device, and the other doctor performed 
manual thrust (Figs. 2 and 3). The same doctors performed the 
different cough techniques and measurements for each pa-
tient. Unassisted PCF was measured by asking the subject to 
cough as forcefully as possible through the Cough Aid; at the 
same time, the pushing bar was pressed to allow air to pass 
Patient
connection
part
MI-E or Ambu bag
connection part
Cough passing
through part
Hole disc
Spring
Pushing bar
Control partConnection part
One-way valve
Fig. 1. Flow analyzer test system. When performing a cough-assistance technique, the air that is inhaled from the MI-E or Ambu bag through the patient 
connection part does not leak though the valve; when the patient exhales or coughs, the pushing bar is pressed at the same time, and the exhaled air is 
pushed through the pushing bar. (A) Disassembled view. (B) Complete view showing the inner parts. MI-E, mechanical in-exsufflator.
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through the Cough Aid.8 A commercial flow analyzer test sys-
tem (Certifier® FA, TSI Inc., Shoreview, MN, USA) belonging to 
the Cough Aid was used to measure PCF.8 Manual-assisted PCF 
following an MIC maneuver was measured by first inducing 
maximal air stacking with an Ambu bag so that MIC was ach-
ieved while the Ambu bag was attached to the connection part 
of the Cough Aid and the pushing bar was not pressed.8 The pa-
tient was then asked to cough when the pushing bar was press-
ed; at the same time, manual abdominal thrust was applied (Fig. 
2). MI-E-assisted PCF was measured after the MI-E (CoughAs-
sist; Respironics, Inc.; Murrysville, PA, USA) was connected to 
the Cough Aid and set to give 40 cm H2O inspiratory pressure 
and -40 cm H2O expiratory pressure.11 The MI-E cycled manu-
ally, which in the present study allowed the experienced reha-
bilitation medicine doctor to coordinate the function of the MI-E 
with the patient’s inspiratory and coughing efforts. The insuf-
flation and exsufflation durations were 3 and 2 seconds, re-
spectively. Each patient received five insufflation-exsufflation 
cycles of MI-E divided by 3-second inter-cycle pauses.4 On the 
fifth application, the subject was asked to produce a maximal 
voluntary cough into the Cough Aid (Fig. 3). The PCF after as-
sistance by MI-E in combination with manual thrust was mea-
sured as described above for the MI-E-assisted PCF, and ab-
dominal thrust was performed by the experienced rehabilitat-
ion medicine doctor to coincide with the cough. All PCF me-
asurements were performed with the patient positioned 60 to 
90 degrees from the supine position during coughing. Each of 
the four maneuvers was conducted at least three times, with 
rest periods between them. The highest values obtained in these 
repeated maneuvers were used for analysis.1 All participants 
underwent the four conditions (no assistance, manual thrust 
following an MIC maneuver, MI-E, and MI-E in combination 
with manual thrust), with a 10-minute washout period be-
tween conditions. The order of the PCF measurements was ran-
domized.
To estimate reliability, two investigators measured the PCF 
using the Cough Aid in 16 normal persons. Each rater mea-
sured the PCF at three separate times at intervals of 1 day with-
out data from previous measurements. Intrarater reliability 
and interrater reliability were evaluated using the intraclass 
correlation coefficient (ICC). Intrarater reliability was within 
the acceptable levels for both raters. The ICCs were found to be 
0.99 and 0.98, respectively. The ICC for interrater reliability 
was 0.98.
Statistical analyses
The four conditions were compared in terms of PCF by using 
a repeated measure analysis of variance. If the repeated mea-
sure analysis of variance detected significant differences, post 
hoc analyses were performed by using a least significant differ-
ence (LSD) test. The analyses were performed using SPSS 20.0 
(SPSS Inc., Chicago, IL, USA), and p values of less than 0.05 
Fig. 2. Measurement of manually assisted peak cough flow following a 
maximum insufflation capacity maneuver.
Fig. 3. Measurement of mechanical insufflation-exsufflator-assisted peak 
cough flow.
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were regarded as statistically significant.
RESULTS
All enrolled participants completed the study. All three cough-
augmentation techniques were well-tolerated, and the atten-
dance rate was 100%. The demographic characteristics and 
pulmonary function test results including respiratory muscle 
strength and spirometry data for the patients are shown in Ta-
ble 1. The average (standard deviation) PCF in the unassisted 
state was 95.7 (40.5) L/min. After manual assistance following 
an MIC maneuver, the PCF was 155.9 (53.1) L/min. After MI-E 
alone and in combination with manual thrust, the PCFs were 
177.2 (33.9) and 202.4 (46.6) L/min, respectively (Table 2). The 
repeated measures analysis of variance indicated that these 
values differed significantly (F=84.92, p<0.01) (Table 2). Use of 
the LSD test revealed that manual assistance following an MIC 
maneuver, MI-E alone, and MI-E plus manual thrust signifi-
cantly improved PCF relative to unassisted PCF (F=84.92, p< 
0.01). Moreover, manual assistance following an MIC maneu-
ver was significantly less effective than MI-E alone or in com-
bination with manual thrust (F=84.92, p<0.01). MI-E plus man-
ual thrust was significantly more effective than MI-E alone 
(F=84.92, p<0.01) (Table 2). The large standard deviations in-
dicated that the PCFs were highly variable. This likely reflected 
the heterogeneity of the patient population in terms of disease 
severity.
DISCUSSION
This was the first clinical trial to demonstrate the superior abili-
ty of an MI-E in combination with manual thrust to improve 
PCF more so than other cough-augmentation techniques in 
ventilator-dependent patients with NMD who had severe de-
grees of PCF impairment. In addition, PCF was measured ob-
jectively by using a new device, the Cough Aid. 
Our study of 40 patients with NMD showed that MI-E alone 
improved PCF significantly more than manual assistance fol-
lowing an MIC maneuver. In contrast, a recent meta-analysis 
failed to detect any significant differences between MI-E and 
other manual cough assistance techniques.5 This disparity be-
tween our study and the meta-analysis may reflect the use of 
different methods of assistance and measuring PCF. More-
over, the MI-E protocol used in our study (i.e., the pressures and 
application times) differed from the protocol used in several 
of the studies that were included in the meta-analyses; the oth-
er studies that were included did not consistently report thee 
MI-E protocol used.12-14 Notably, our results are consistent with 
those of Bach4 in 21 patients with NMD; they found that man-
ual assistance after maximal insufflation was not as effective 
as an MI-E in terms of increasing PCF. However, it should be 
noted that Bach did not randomize the delivery of the inter-
ventions; instead, manual assistance following an MIC ma-
neuver was always followed by the MI-E, which may have in-
troduced selection bias. Conversely, in the present study, the 
four conditions (no assistance, manual assistance following 
an MIC maneuver, assistance using an MI-E, and assistance us-
ing both an MI-E and manual thrust) were delivered in random 
order. Our study contrasts somewhat from the study of Senent, 
et al.,6 who examined 16 patients with ALS; they found that 
while the PCFs produced by manual thrust after maximum 
insufflation were smaller on average than those produced 
when an MI-E was used, this difference did not achieve statis-
tical significance. This disparity may reflect the fact that Se-
nent, et al. performed four to six insufflation-exsufflation cycles 
with 1- to 3-second inter-cycle pauses, although this protocol 
Table 1. Demographic Characteristics and Pulmonary Function Data for 
the Subjects (n=40)
Variables Values
Age (yrs) 20.9±7.2
Sex (male:female) 37:3
FVC (mL) 667.4±313.4
  (%FVC=FVC/FVCpre) (17.9±10.2)
MIP (cm H20) 19.5±10.2
  (%MIP=MIP/MIPpre) (19.1±10.3)
MEP (cm H20) 25.3±19.6
  (%MEP=MEP/MEPpre) (16.0±12.7)
Diagnosis 
Duchenne muscular dystrophy 20
Spinal muscular atrophy 13
Progressive muscular dystrophy 5
Myasthenia gravis 1
Congenital myopathy 1
FVC, forced vital capacity; FVCpre, predicted value of forced vital capacity; 
MIP, maximal inspiratory pressure; MIPpre, predicted value of maximal inspi-
ratory pressure; MEP, maximal expiratory pressure; MEPpre, predicted value 
of maximal expiratory pressure.
Values are mean±standard deviation.
Table 2. Comparison of Peak Cough Flows among Four Different Conditions
UPCF MPCF-MIC PCF-MI-E PCF-MI-EM F value 
PCF (L/min) 95.7±40.5 155.9±53.1 177.2±33.9 202.4±46.6 84.92*
PCF, peak cough flow; UPCF, unassisted peak cough flow; MPCF-MIC, manual assisted peak cough flow following a maximal insufflation capacity maneuver; PCF-
MI-E, mechanical insufflation-exsufflator-assisted peak cough flow; PCF-MI-EM, peak cough flow after assistance by mechanical insufflation-exsufflator in com-
bination with manual thrust.
Values are mean±standard deviation. 
*p<0.01. 
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was apparently not applied consistently. Moreover, the insuf-
flation and exsufflation durations were not reported. In con-
trast, we always performed five cycles of 3-second insufflation 
and 2-second exsufflation; moreover, the cycles were always 
interspersed by 3-second pauses. In addition, the cohorts in 
our and Senent, et al.’s studies differed markedly: all subjects in 
the study by Senent, et al. had ALS, some of whom had very se-
vere bulbar symptoms. In contrast, all subjects in the present 
study had hereditary NMD, mainly Duchenne muscular dys-
trophy and spinal muscular atrophy. Effective coughing re-
quires that the upper airway muscles coordinate glottis closure 
and opening; this process can be impaired in ALS.6 Thus, the 
different disease courses and outcomes of ALS and NMD in-
dicate that studies on ALS should be considered separately 
from studies on hereditary NMD. In contrast with our results, 
in a study by Lacombe, et al.7 conducted on 18 patients with 
NMD, PCF was higher when using an insufflation technique 
combined with manual assistance than when using an MI-E 
combined with manual assistance or an MI-E alone. They also 
suggested that adding the MI-E device to manual assistance 
was unhelpful in patients whose PCF when using an insuffla-
tion technique and manual assistance exceeded 5 L/s, as the 
expiratory flow produced by the patient’s effort and manual 
assistance transitorily exceeded the vacuum capacity of the 
MI-E device, which therefore became a transient load against 
the PCF.7 However, the conditions differed between this study 
and our own. In the present study, the average PCF in the un-
assisted state of the cohort was only 95.7±40.5 L/min, and af-
ter manual assistance following an MIC maneuver, the average 
PCF was 155.9±53.1 L/min (i.e., 2.6±0.9 L/s), which was much 
less than 5 L/s. This may in part explain the differences in the 
results between the studies. Cough ability increasingly de-
clines as the disease progresses in NMD patients, and a weak 
cough is an important factor that contributes to respiratory 
morbidity.8 Increasing cough flow would improve secretion 
clearance, which in turn could improve the clinical outcomes 
of patients with NMD in terms of morbidity and possibly sur-
vival.4 Thus, it is important that the MI-E in combination with 
manual thrust improves cough ability more than other cough-
augmentation techniques in predominantly advanced-stage 
NMD patients. 
Bach4 hypothesized that, should MI-E be used in conjunction 
with the manual thrust technique, it would tend to decrease 
the transtracheal pressure gradient; this in turn would cause 
the airway to collapse somewhat during exsufflation, thereby 
enhancing airway secretion elimination. However, whether an 
MI-E combined with manual thrust actually does improve PCF 
was not confirmed in a controlled clinical setting until the pres-
ent study, although the combined approach was used in a pre-
vious study.7,15 We indeed found that in noninvasive ventilator-
dependent patients with NMD with severe respiratory muscle 
dysfunction, an MI-E in combination with manual thrust was 
markedly superior to either an MI-E alone or manual assistance 
following an MIC maneuver and also did not induce any ad-
verse effects. The findings of the present study are in line with 
the findings of Sivasothy, et al.,12 who found that in 12 subjects 
with respiratory muscle weakness without scoliosis, mechani-
cal assistance plus manual thrust significantly improved PCF 
relative to unassisted coughing. However, it should be noted 
that in their study, the mechanical insufflation and exsuffla-
tion pressures were set at 20 and -20 cm H2O, respectively, 
which may not be adequate as several studies show that to 
achieve clinical efficacy, these MI-E pressures should be set at 
40 and -40 cm H2O, respectively.11,16-18 In addition, the MI-E 
protocol used by Sivasothy, et al. differed from ours in that it 
started with two insufflation-exsufflation cycles to aid inflation 
and deflation of the thorax; after a third inspiration, PCF mea-
surements were obtained during coughing with manual thrust 
after the patient was disconnected from the MI-E at the end of 
the insufflation. In other words, they did not use mechanical 
exsufflation during the cough itself. However, in our study, 
PCF measurements were obtained during coughing with man-
ual thrust and simultaneous exsufflation assistance derived 
from the MI-E.
Our study yielded several notable findings. First, we used a 
new device, the Cough Aid, to measure assisted PCF accurate-
ly. In the study of Lacombe, et al.,7 transient positive face mask 
pressure was induced by expiration produced by the com-
bined cough effort and manual assistance during mechanical 
expiration in certain subjects. In that case, the MI-E device and 
its circuitry constituted a load against PCF. However, the Cough 
Aid can distinguish the airflow caused by the MI-E from the 
airflow produced by the patient’s cough, allowing the mea-
surement of PCF alone. Thus, the MI-E device and its circuitry 
could not constitute a load against PCF in any case of our study, 
and objective measurement of PCF was possible. Second, the 
additional benefit of an MI-E in conjunction with the manual 
thrust technique was proven in terms of the PCF response to 
cough assistance techniques in clinical practice. This method 
produced high expiratory flows without raising safety issues. 
Additionally, this study used a larger group of NMD patients 
with advanced respiratory muscle weakness in comparison to 
previous studies. We also used standard protocol for MI-E 
therapy, whereas the pressures, times, and application of the 
MI-E amongst the earlier studies varied and were not consis-
tently reported.5
The present study had three limitations. First, our results 
must be interpreted with caution, as our patients predominant-
ly had advanced stage NMD and thus had respiration insuffi-
ciency that required non-invasive mechanical ventilation. This 
may limit the generalizability of our results to other NMD pop-
ulations. Second, we only investigated the immediate effect of 
an MI-E with or without manual thrust in a clinical setting. Whe-
ther chronic use of this approach would continue to be effec-
tive in the long term remains to be tested. Finally, our data 
were expressed as average results for the patient cohort. As a 
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result, individual variations were obscured. For instance, we 
noticed that several of our patients had better PCFs when man-
ual assistance following an MIC maneuver was used compared 
to when an MI-E alone was employed.
Our study showed that in noninvasive ventilator-dependent 
patients with NMD with respiratory muscle weakness, an MI-E 
produced on average superior PCFs compared to manual 
thrust after maximal insufflation. In addition, an MI-E used in 
conjunction with manual thrust yielded the highest PCFs by a 
significant margin among a range of cough-augmentation te-
chniques.
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